• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神分裂症患者额皮质神经元中腺苷受体 mRNA 的表达。

Adenosine Receptor mRNA Expression in Frontal Cortical Neurons in Schizophrenia.

机构信息

Department of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614, USA.

Department of Pharmacology and Systems Physiology, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.

出版信息

Cells. 2023 Dec 22;13(1):32. doi: 10.3390/cells13010032.

DOI:10.3390/cells13010032
PMID:38201235
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10778287/
Abstract

Schizophrenia is a devastating neuropsychiatric disorder associated with the dysregulation of glutamate and dopamine neurotransmitter systems. The adenosine system is an important neuroregulatory system in the brain that modulates glutamate and dopamine signaling via the ubiquitously expressed adenosine receptors; however, adenosine A and A receptor (AR and AR) mRNA expression is poorly understood in specific cell subtypes in the frontal cortical brain regions implicated in this disorder. In this study, we assayed AR and AR mRNA expression via qPCR in enriched populations of pyramidal neurons, which were isolated from postmortem anterior cingulate cortex (ACC) tissue from schizophrenia ( = 20) and control ( = 20) subjects using laser microdissection (LMD). AR expression was significantly increased in female schizophrenia subjects compared to female control subjects (t = -4.008, = 0.001). AR expression was also significantly decreased in female control subjects compared to male control subjects, suggesting sex differences in basal AR expression (t = 2.137, = 0.047). A significant, positive association was found between dementia severity (clinical dementia rating (CDR) scores) and AR mRNA expression (Spearman's r = 0.424, = 0.009). AR mRNA expression was significantly increased in unmedicated schizophrenia subjects, suggesting that AR expression may be normalized by chronic antipsychotic treatment (F = 9.259, = 0.009). Together, these results provide novel insights into the neuronal expression of adenosine receptors in the ACC in schizophrenia and suggest that receptor expression changes may be sex-dependent and associated with cognitive decline in these subjects.

摘要

精神分裂症是一种严重的神经精神疾病,与谷氨酸和多巴胺神经递质系统的失调有关。腺苷系统是大脑中一种重要的神经调节系统,通过广泛表达的腺苷受体调节谷氨酸和多巴胺信号;然而,在与该疾病相关的额皮质脑区的特定细胞亚型中,腺苷 A 和 A 受体(AR 和 AR)mRNA 表达的理解很差。在这项研究中,我们通过 qPCR 检测了通过激光微切割(LMD)从精神分裂症(n = 20)和对照组(n = 20)死后前扣带皮层(ACC)组织中分离的富含锥体神经元群体中的 AR 和 AR mRNA 表达。与女性对照组相比,女性精神分裂症患者的 AR 表达显著增加(t = -4.008,p = 0.001)。与男性对照组相比,女性对照组的 AR 表达也显著降低,表明 AR 表达存在性别差异(t = 2.137,p = 0.047)。AR 表达与痴呆严重程度(临床痴呆评定量表(CDR)评分)呈显著正相关(Spearman r = 0.424,p = 0.009)。未用药的精神分裂症患者的 AR mRNA 表达显著增加,表明 AR 表达可能通过慢性抗精神病治疗得到正常化(F = 9.259,p = 0.009)。这些结果为精神分裂症 ACC 中腺苷受体的神经元表达提供了新的见解,并表明受体表达变化可能依赖于性别,并与这些患者的认知能力下降有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5056/10778287/eb7ebd5b6b99/cells-13-00032-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5056/10778287/99c3113b8fa8/cells-13-00032-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5056/10778287/79a079fee7d2/cells-13-00032-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5056/10778287/cac374b64c19/cells-13-00032-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5056/10778287/c83a94286ac2/cells-13-00032-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5056/10778287/bdaf87ee6592/cells-13-00032-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5056/10778287/eb7ebd5b6b99/cells-13-00032-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5056/10778287/99c3113b8fa8/cells-13-00032-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5056/10778287/79a079fee7d2/cells-13-00032-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5056/10778287/cac374b64c19/cells-13-00032-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5056/10778287/c83a94286ac2/cells-13-00032-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5056/10778287/bdaf87ee6592/cells-13-00032-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5056/10778287/eb7ebd5b6b99/cells-13-00032-g006.jpg

相似文献

1
Adenosine Receptor mRNA Expression in Frontal Cortical Neurons in Schizophrenia.精神分裂症患者额皮质神经元中腺苷受体 mRNA 的表达。
Cells. 2023 Dec 22;13(1):32. doi: 10.3390/cells13010032.
2
Adenosine Metabolism Pathway Alterations in Frontal Cortical Neurons in Schizophrenia.精神分裂症患者前额皮质神经元中的腺苷代谢途径改变。
Cells. 2024 Oct 6;13(19):1657. doi: 10.3390/cells13191657.
3
Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment.精神分裂症患者死后额叶皮质中A2A腺苷、D2多巴胺和CB1大麻素受体的免疫密度及mRNA表达:抗精神病药物治疗的影响
Psychopharmacology (Berl). 2009 Oct;206(2):313-24. doi: 10.1007/s00213-009-1608-2. Epub 2009 Aug 4.
4
Cell-subtype-specific changes in adenosine pathways in schizophrenia.精神分裂症中腺苷途径的细胞亚型特异性变化。
Neuropsychopharmacology. 2018 Jul;43(8):1667-1674. doi: 10.1038/s41386-018-0028-6. Epub 2018 Feb 26.
5
Glutamate transporter splice variant expression in an enriched pyramidal cell population in schizophrenia.精神分裂症中富集锥体细胞群中谷氨酸转运体剪接变体的表达
Transl Psychiatry. 2015 Jun 9;5(6):e579. doi: 10.1038/tp.2015.74.
6
The antidepressant-like effect of guanosine involves the modulation of adenosine A and A receptors.鸟苷的抗抑郁样作用涉及到对腺苷 A1 和 A2 受体的调节。
Purinergic Signal. 2023 Jun;19(2):387-399. doi: 10.1007/s11302-022-09898-8. Epub 2022 Sep 27.
7
Caffeine and adenosine A receptors rescue neuronal development in vitro of frontal cortical neurons in a rat model of attention deficit and hyperactivity disorder.咖啡因和腺苷 A 受体可挽救注意缺陷多动障碍大鼠模型额皮质神经元体外发育障碍
Neuropharmacology. 2020 Apr;166:107782. doi: 10.1016/j.neuropharm.2019.107782. Epub 2019 Nov 19.
8
Reduced striatal adenosine A2A receptor levels define a molecular subgroup in schizophrenia.纹状体腺苷A2A受体水平降低定义了精神分裂症中的一个分子亚组。
J Psychiatr Res. 2014 Apr;51:49-59. doi: 10.1016/j.jpsychires.2013.12.013. Epub 2014 Jan 7.
9
Decreased striatal adenosine A-dopamine D receptor heteromerization in schizophrenia.精神分裂症中纹状体腺苷A-多巴胺D受体异聚体减少。
Neuropsychopharmacology. 2021 Feb;46(3):665-672. doi: 10.1038/s41386-020-00872-9. Epub 2020 Oct 3.
10
Enabling role of adenosine A1 receptors in adenosine A2A receptor-mediated striatal expression of c-fos.腺苷A1受体在腺苷A2A受体介导的纹状体c-fos表达中的促成作用。
Eur J Neurosci. 2003 Jul;18(2):296-302. doi: 10.1046/j.1460-9568.2003.02747.x.

引用本文的文献

1
Ketogenic diet, adenosine, and dopamine in addiction and psychiatry.生酮饮食、腺苷与成瘾及精神病学中的多巴胺
Front Nutr. 2025 Mar 10;12:1492306. doi: 10.3389/fnut.2025.1492306. eCollection 2025.
2
Purinergic System Transcript Changes in the Dorsolateral Prefrontal Cortex in Suicide and Major Depressive Disorder.自杀和重度抑郁症患者背外侧前额叶皮质中嘌呤能系统转录本的变化
Int J Mol Sci. 2025 Feb 20;26(5):1826. doi: 10.3390/ijms26051826.
3
Adenosine Metabolism Pathway Alterations in Frontal Cortical Neurons in Schizophrenia.精神分裂症患者前额皮质神经元中的腺苷代谢途径改变。

本文引用的文献

1
The adenosine hypothesis of schizophrenia into its third decade: From neurochemical imbalance to early life etiological risks.精神分裂症的腺苷假说进入第三个十年:从神经化学失衡到早期生活病因风险。
Front Cell Neurosci. 2023 Mar 14;17:1120532. doi: 10.3389/fncel.2023.1120532. eCollection 2023.
2
Profiling cell-type specific gene expression in post-mortem human brain samples through laser capture microdissection.通过激光捕获显微切割技术对人死后脑组织样本中的细胞类型特异性基因表达进行分析。
Methods. 2022 Nov;207:3-10. doi: 10.1016/j.ymeth.2022.08.013. Epub 2022 Sep 3.
3
Cerebral A adenosine receptor availability in female and male participants and its relationship to sleep.
Cells. 2024 Oct 6;13(19):1657. doi: 10.3390/cells13191657.
4
Metabolic Insights into Neuropsychiatric Illnesses and Ketogenic Therapies: A Transcriptomic View.代谢洞察神经精神疾病和生酮疗法:转录组学观点。
Int J Mol Sci. 2024 Jul 29;25(15):8266. doi: 10.3390/ijms25158266.
女性和男性参与者大脑 A 腺苷受体的可用性及其与睡眠的关系。
Neuroimage. 2021 Dec 15;245:118695. doi: 10.1016/j.neuroimage.2021.118695. Epub 2021 Oct 31.
4
Adenosine A receptor in schizophrenia: an in vivo brain PET imaging study.精神分裂症中的腺苷 A 受体:一项体内脑 PET 成像研究。
Psychopharmacology (Berl). 2022 Nov;239(11):3439-3445. doi: 10.1007/s00213-021-05900-0. Epub 2021 Jun 26.
5
ADORA2A variation and adenosine A receptor availability in the human brain with a focus on anxiety-related brain regions: modulation by ADORA1 variation.ADORA2A 变异与人类大脑中的腺苷 A 受体可用性:ADORA1 变异的调节作用及其与焦虑相关脑区的关系
Transl Psychiatry. 2020 Nov 24;10(1):406. doi: 10.1038/s41398-020-01085-w.
6
Decreased striatal adenosine A-dopamine D receptor heteromerization in schizophrenia.精神分裂症中纹状体腺苷A-多巴胺D受体异聚体减少。
Neuropsychopharmacology. 2021 Feb;46(3):665-672. doi: 10.1038/s41386-020-00872-9. Epub 2020 Oct 3.
7
Potential antipsychotic action of the selective agonist of adenosine A1 receptors, 5'-Cl-5'-deoxy-ENBA, in amphetamine and MK-801 rat models.选择性腺苷 A1 受体激动剂 5'-Cl-5'-脱氧 ENBA 在安非他命和 MK-801 大鼠模型中的潜在抗精神病作用。
Pharmacol Rep. 2020 Jun;72(3):580-588. doi: 10.1007/s43440-020-00093-3. Epub 2020 Mar 26.
8
Adenosine A receptor as potential therapeutic target in neuropsychiatric disorders.腺苷 A 受体在神经精神疾病中的潜在治疗靶点。
Pharmacol Res. 2019 Sep;147:104338. doi: 10.1016/j.phrs.2019.104338. Epub 2019 Jul 2.
9
Neuron-specific deficits of bioenergetic processes in the dorsolateral prefrontal cortex in schizophrenia.精神分裂症患者背外侧前额叶皮层神经元生物能量过程的特异性缺陷。
Mol Psychiatry. 2019 Sep;24(9):1319-1328. doi: 10.1038/s41380-018-0035-3. Epub 2018 Mar 1.
10
Cell-subtype-specific changes in adenosine pathways in schizophrenia.精神分裂症中腺苷途径的细胞亚型特异性变化。
Neuropsychopharmacology. 2018 Jul;43(8):1667-1674. doi: 10.1038/s41386-018-0028-6. Epub 2018 Feb 26.